| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.26 | 0.07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.08 |